Diane D. Torcello - 09 Nov 2026 Form 4 Insider Report for TOMPKINS FINANCIAL CORP (TMP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Nov 2026, 13:42:10 UTC
Prior SEC filing
29 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Diane D. Torcello
Filing notes and source

Key filing fact

Diane D. Torcello filed Form 4 for TOMPKINS FINANCIAL CORP (TMP) on 12 Nov 2026.

Key facts

  • This page summarizes Diane D. Torcello's Form 4 filing for TOMPKINS FINANCIAL CORP (TMP).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 13:42.

Change

  • Previous filing in this sequence was filed on 29 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001975155 Primary reporting owner

Torcello Diane D

Relationship
EVP & President, Tompkins WNY
Address
PO BOX 460, ITHACA
Signature
/s/ Diane D. Torcello
Signature date
11 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMP transaction

Common Stock

Award

Transaction value
Shares
+675
Change %
+9.1%
Price
$100.76*
Shares after
8,053
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1
TMP transaction

Common Stock

Tax liability

Transaction value
Shares
-37
Change %
-0.46%
Price
$100.76*
Shares after
8,016
Date
09 Nov 2026
Ownership
Direct
Footnotes
F2
TMP transaction

Common Stock

Tax liability

Transaction value
Shares
-38
Change %
-0.47%
Price
$100.76*
Shares after
7,978
Date
09 Nov 2026
Ownership
Direct
Footnotes
F2
TMP transaction

Common Stock

Tax liability

Transaction value
Shares
-105
Change %
-1.3%
Price
$100.76*
Shares after
7,873
Date
09 Nov 2026
Ownership
Direct
Footnotes
F2
TMP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,994
Date
09 Nov 2026
Ownership
By ESOP

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMP holding Derivative

Stock Appreciation Rights (SAR)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
09 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
0
Exercise price
$49.22
Footnotes
F3
TMP holding Derivative

Stock Appreciation Rights (SAR)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
09 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
0
Exercise price
$76.90
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted stock was granted pursuant to the Tompkins Financial Corporation 2019 Equity Incentive Plan. Restricted stock grants have a five-year vesting schedule with 0% vesting in year one and 25% vesting in years two through five. The grant will expire ten years from the date of the grant.

Footnote F2

Deemed disposition of shares to the Issuer to pay for taxes upon vesting of restricted stock.

Footnote F3

Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.

Footnote F4

Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a five-year vesting schedule, with 0% vesting in year one and 25% vesting in years two through five. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .